Journal article
Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer Does Histotype and Stage Matter?
Abstract
OBJECTIVE: To examine the performance of the Risk of Malignancy Index (RMI) and Risk of Ovarian Malignancy Algorithm (ROMA) by histologic subtype and stage of disease in a cohort of women with ovarian cancer.
METHODS: All patients with confirmed ovarian cancer at the Princess Margaret Hospital between February 2011 and January 2013 were eligible for study inclusion. Preoperative cancer antigen 125, human epididymis protein 4, and ultrasound …
Authors
Lennox GK; Eiriksson LR; Reade CJ; Leung F; Mojtahedi G; Atenafu EG; Ferguson SE; Murphy J; Diamandis EP; Kulasingam V
Journal
International Journal of Gynecological Cancer, Vol. 25, No. 5, pp. 809–814
Publisher
Elsevier
Publication Date
June 2015
DOI
10.1097/igc.0000000000000442
ISSN
1048-891X